Conference on patient compliance. Somerset, NJ: Healthcare Compliance Packaging Council. May 18–19, 1993.
2.
Talk about prescriptions month. Oct 1991 Planning Guide: 1–20.
3.
Emerging issues in pharmaceutical cost containment. Reston, VA: National Pharmaceutical Council1992; 2 (2): 1–16.
4.
McKenneyJMHarrisonWL. Drug-related hospital admissions. Am J Hosp Pharm1976; 33: 792–5.
5.
Health beliefs, compliance—hypertension. JAMA1990; 264: 2864.
6.
Personal communication, R. Levy, Ph.D. Patient Medication Compliance Meeting, Bristol-Myers Squibb. Washington, DC, July 14, 1992.
7.
Personal communication, J. Hammond, B.S.Pharm. Patient Medication Compliance Meeting, Bristol-Myers Squibb. Washington, DC, July 14, 1992.
8.
Personal communication, B. Svarstad, Ph.D. Patient Medication Compliance Meeting, Bristol-Myers Squibb. Washington, DC, July 14, 1992.
9.
SclarDAChinASkaerTLOkamotoMPNakahiroRKGillMA. Effect of health education on the utilization of antihypertensive therapy: a prospective trial among HMO enrollees. Prim Cardiol1992; (suppl 1): 24–9.
10.
Improving medication compliance. Proceedings of a symposium. Washington, DC: National Pharmaceutical Council, 1985.
11.
Schering Report IX. Kenilworfh, NJ: Schering Laboratories.
12.
BurgessMM. Ethical and economic aspects of noncompliance and overtreatment. Can Med Assoc J1989; 141: 777–80.
13.
LevyRASmithDL. Staying the course refill reminders can boost sales. Pharm Exec1989; 9: 72–8.
14.
ClepperI. Noncompliance. The invisible epidemic. Drug Topics1992.
15.
FrancisCK. Hypertension, cardiac disease, and compliance in minority patients. Am J Med1991; 91 (suppl 1A): 29S–36S.
16.
DwyerMSLevyRAMenanderKB. Improving medication compliance through the use of modem dosage forms. J Pharm Technol1986; 2: 166–70.
17.
MorganTONowsonCMurphyJSnowdenR. Compliance and the elderly hypertensive. Drugs1986; 31 (suppl 4): 174–83.
18.
SmithD. Compliance packaging: a patient education tool (letter). Am Pharm1989; NS29: 127.
19.
Survey by Applied Research Techniques conducted for the American Association of Retired Persons. Washington, DC: American Association of Retired Persons, 1984.
20.
Schering Report XIV. Kenilworth, NJ: Schering Laboratories, 1–12.
21.
National prescription buyers survey. Kalamazoo, MI: The Upjohn Company, 1985.
22.
UrquhartJChevalleyC. Impact of unrecognized dosing errors on the cost and effectiveness of pharmaceuticals. Drug Inf J1988; 22: 363–78.
23.
PullarTFeelyM. Problems of compliance with drug treatment: new solutions?Pharm J1990; 245: 213–5.
24.
CloydJCKrielRLJones-SaeteCMOngBYJancikJTRemmelRP. Comparison of sprinkle versus syrup formulations of valproate for bioavailability, tolerance, and preference. J Pediatr1992; 120 (4 pt 1): 634–8.
25.
BurrisJFPapademetriouVWallinJDCookMEWeidlerDJ. Therapeutic adherence in the elderly: transdermal clonidine compared to oral verapamil for hypertension. Am J Med1991; 91 (suppl 1A): 22S–8S.
26.
Drug Ther Bull1991; 29: 1–2.
27.
HaskittRL. Patient compliance: tapping into a billion-dollar drug market. Pharm Exec1989: 46–52.
28.
The NCPIE News1991; 1 (2): 1–8.
29.
Am J Hosp Pharm1992; 49: 1613.
30.
LevinsonW. Physician-patient communication in the managed care environment. Med Interface1991; May: 13–14, 16, 62.
31.
The NPC Report 1988;Winter:l–8.
32.
SimkinsCVWenzloffNJ. Evaluation of a computerized reminder system in the enhancement of patient medication refill compliance. Drug Intell Clin Pharm1986; 20: 799–802.
33.
SclarDA. Medication compliance: central and peripheral routes to persuasion. Summary report.
34.
Drug Topics May 2, 1988.
35.
Personal communication, H. Linden, Swedish Drug Information Council, July 1992.
36.
ASHP guidelines on pharmacy conducted patient counseling. Am J Hosp Pharm1993; 50: 505–6.
37.
Patient compliance to prescribed antihypertensive medication regimens: a report to the National Heart, Lung, and Blood Institute. Sponsored by the Behavioral Medicine Branch, Division of Heart and Vascular Diseases, National Heart, Lung, and Blood Institute; 1980 (NIH Publication No. 81-2101).
38.
KuperbergJRSmithDLVogtEM. All in one: the user-friendly Rx product. Pharm Exec1990; Apr: 74–8.
39.
Personal communication, D. Sclar, Ph.D. Patient Medication Compliance Meeting, Bristol-Myers Squibb. Washington, DC, July 14, 1992.
40.
American Pharmaceutical Association Board of Trustees. The role of pharmacists in comprehensive use manuscript. Washington, DC: American Pharmaceutical Association, March 1992.
41.
DebrovnerD. Compliance programs are popping up all over—but not all pharmacists like them. Am Druggist1992; Nov: 60–6.
42.
The ICD- 10 classification of mental and behavioral disorders—clinical discretions and diagnostic guidelines. Geneva: World Health Organization, 1992.
43.
BectelMQ. Improving patient compliance. Am Pharm1984; NS24 (8): 58–60. Big brother may soon be another party to every drug prescription transaction. Psychiatr News 1992; (July 3): 4, 12.
44.
BlanchardRBergerWBailieGREiseleG. Knowledge of hemodialysis and CAPD patients about their prescribed medicines. Clin Nephrol1990; 34: 173–8.
45.
BondWSHussarDA. Detection methods and strategies for improving medication compliance. Am J Hosp Pharm1991; 48: 1978–88.
46.
BuchananNShuenyaneEMashigoSMtangaiPUnterhalterB. Factors influencing drug compliance in ambulatory black urban patients. S Afr Med J1979; 55: 368–73.
47.
CacciatoreLCeccarelliGCiampiniMControlled multicenter clinical comparison between two cefatrizine administration schedules: a contribution to improvement of compliance in clinical nonhospital use of antibiotics. Clin Ther1988; 10: 266–75.
48.
CartwrightA. Medicine taking by people aged 65 or more. Br Med Bull1990; 46: 63–76.
49.
CharneyEBynumREldredgeDFrankDMacWhinneyJBMcNabbNHow well do patients take oral penicillin? A collaborative study in private practice. Pediatrics1967; 40: 188–95.
50.
CheckWA. New drugs and drug delivery systems in the year 2000. Am Pharm1984; NS24 (9): 44–56.
51.
ChristensenDB. Drug-taking compliance: a review and synthesis. Health Serv Res1978; 13: 171–87.
52.
ClarkLT. Improving compliance and increasing control of hypertension: needs of special hypertensive populations. Am Heart J1991; 121 (2pt2): 664–9.
53.
ClintonJJ. From the Agency for Healthcare Policy and Research. JAMA1990; 263: 2158.
54.
CockburnJGibberdRWReidALSanson-FisherRW. Determinants of non-compliance with short term antibiotic regimens. Clin Res Educ1987; 295: 814–8.
55.
CockburnJReidALBowmanJASanson-FisherRW. Effects of intervention on antibiotic compliance in patients in general practice. Med J Aust1987; 147: 324–8.
56.
ColNFanaleJEKronholmP. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med1990; 150: 841–5.
57.
ColletteJLudwigEG. Patient compliance with medical advice. J Natl Med Assoc1969; 61: 408–11.
58.
CombsDLO'BrienRJGeiterLJ. USPHS tuberculosis short-course chemotherapy trial 21: effectiveness, toxicity, and acceptability. Ann Intern Med1990; 112: 397–406.
59.
CookCA. Antihypertensive drug compliance in black males. J Natl Med Assoc1984; 61: 177–83.
60.
CorriganPWLibermanRPEngelJD. From noncompliance to collaboration in the treatment of schizophrenia. Hosp Commun Psychiatry1990; 41: 1203–11.
DowMGVerdiMBSaccoWP. Training psychiatric patients to discuss medication issues: effects on patient communication and knowledge of medications. Behav Modif1991; 15: 3–21.
70.
EisenSAMillerDKWoodwardRSSpitznagelEPrzybeckTR. The effect of prescribed daily dose frequency on patient medication. Arch Intern Med1990; 150: 1881–4.
71.
EisenbergH. You're doing something right. Med Econ1990;(April 23):50–5. Electronic cap device helps medication compliance in hypertensive patients. Am J Hosp Pharm 1992;49:1613.
72.
FDC Rep1989;Oct 23:T&G-8-T&G-9.
73.
FDC Rep1990;Mar 5:T&G-9.
74.
FeinsteinAR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med1990; 150: 1377–9.
75.
FinchamJEWertheimerAI. Initial drug noncompliance in the elderly. J Geriatr Drug Ther1986; 1: 19–29.
76.
FreundAJohnsonSBSilversteinJThomasJ. Assessing daily management of childhood diabetes using 24-hour recall interviews: reliability and stability. Health Psychol1991; 10: 200–8.
77.
From the Centers for Disease Control: health beliefs, compliance—hypertension. JAMA1990; 264: 2864.
78.
GabrielMGagnonJPBryanCK. Improved patient compliance through use of a daily drug reminder chart. Am J Public Health1977; 67: 968–9.
79.
GilchristWJLeeYCTarnHCMacdonaldJBWilliamsBO. Prospective study of drug reporting by general practitioners for an elderly population referred to a geriatric service. Br Med J1987; 294: 289–90.
80.
GillumRFBarskyAJ. Diagnosis and management of patient noncompliance. JAMA1974; 228: 1563–7.
81.
GreenbergRN. Overview of patient compliance with medication dosing: a literature review. Clin Ther1984; 6: 592–9.
82.
HagopianGAHymovichDP. Education materials: do it yourself. Office Nurse1990;Jan/Feb:24–7.
83.
HallDWilesDHMcCreadieRG. Compliance with antidepressant medication. Br J Psych1990; 157: 453–4.
84.
HallasJHarvaldBGramLFGrodumEBrosenKHaghfeltTDrug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med1990; 228: 83–90.
85.
HamiltonRABricelandLL. Use of prescription-refill records to assess patient compliance. Am J Hosp Pharm1992; 49: 1691–6.
86.
Hayes-BautistaDE. Modifying the treatment: patient compliance, patient control and medical care. Soc Sci Med1976; 10: 233–8.
87.
HaynesRB. Physician interventions to improve compliance. Geriatr Consult1986;July/Aug:20–9.
88.
HaynesRBSackettDLTaylorDWRobertsRSJohnsonAL. Manipulation of the therapeutic regimen to improve compliance: conceptions and misconceptions. Clin Pharm Ther1977; 22: 125–30.
89.
Helping patients to make the best use of medicines. Drug Ther Bull1991; 29 (1): 1–2.
90.
HidayVAScheid-CookTL. Outpatient commitment for “revolving door” patients: compliance and treatment. J Nerv Ment Dis1991; 179: 83–8.
91.
HoflingBHoyningen-HueneKY. Effects of different once-a-day medications on 24-hour blood pressure recordings in hypertensives. Chronobiol Int1991; 8: 477–84.
92.
HusseyLC. Overcoming the clinical barriers of low literacy and medication noncompliance among the elderly. J Gerontol Nurs1991; 17: 27–9.
93.
Improving compliance in HT, hypercholesterolemia. Intern Med News1991; June 1–14: 24.
94.
JanzNBeckerM. The health belief model: a decade later. Health Educ Q1984; 11: 1–47.
95.
JohannsenWJHellmuthGASoraufT. On accepting medical recommendations. Arch Environ Health1966; 12: 63–9.
96.
JoyceCRB. Patient co-operation and the sensitivity of clinical trials. J Chronic Dis1962; 15: 1025–36.
97.
JoyceCRBCapleGMasonMReynoldsEMathewsJA. Quantitative study of doctor-patient communication. Q J Med1969; 38: 183–94.
98.
KaldorA. How to comply with non-compliance. Int J Con Pharmacol Ther Toxicol1991; 29: 209.
99.
KatzLG. The use of printed instruction sheets to enhance patient compliance. Semin Dermatol1991; 10: 91–5.
100.
KeenPJ. What is the best dosage schedule for patients?J R Soc Med1991; 84: 640–1.
101.
KellyGRScottJE. Medication compliance and health education among outpatients with chronic mental disorders. Med Care1990; 28: 1181–97.
102.
KoltonKAPiccoloP. Patient compliance: a challenge in practice. Nurse Pract1988; 13 (12): 37–49.
103.
KoonerKSZimmermanTJ. A glaucoma medication time-table card. Ann Ophthalmol1986; 19: 43–4.
104.
KrollJLindePHabenichtMChanSYangMVangTMedication compliance, antidepressant blood levels, and side effects in Southeast Asian patients. J Clin Psychopharmacol1990; 10: 279–83.
LarratEPTaubmanAHWilleyC. Compliance-related problems in the ambulatory population. Am Pharm1990; NS30 (2): 18–23.
107.
LatiolaisCJBerryCC. Misuse of prescription medications by outpatients. Drug Intell Clin Pharm1969; 3: 270–7.
108.
Lederle program promotes pharmacist's role in helping smokers quit. Am J Hosp Pharm1992; 49: 1614.
109.
LeePTanLJ. Drug compliance in outpatients with rheumatoid arthritis. Aust N Z J Med1979; 9: 274–7.
110.
LevineDM. Improving adherence to antihypertensive regimens among the elderly. Geriatr Med Today1991; 10 (1): 58–65.
111.
LevyRA. Improving compliance with prescription medications: an important strategy for containing health-care costs. Med Interface1989; March: 34–6, 41.
112.
LeyPBradshawPWEavesDWalkerCM. A method for increasing patients' recall of information presented by doctors. Psychol Med1973; 3: 217–20.
113.
LeyPSpelmanMS. Communications in an out-patient setting: Br J Soc Clin Psychol1965; 4: 114–6.
114.
LinkewichJACatalanoRBFlackHL. The effect of packaging and instruction on outpatient compliance with medication regimens. Drug Intell Clin Pharm1974; 8: 10–5.
115.
LisiDM. Initial drug noncompliance (letter). DICP Ann Pharmacother1990; 24: 641.
116.
LoganRPHGummettPAMisiewiczJJKarimQNWalkerMMBaronJH. One week eradication regimen for Helicobacter pylori. Lancet1991; 338: 1249–52.
ManasseHR. Medication use in an imperfect world: drug misadventuring as an issue of public policy, part 1. Am J Hosp Pharm1989; 46: 929–44.
119.
ManasseHR. Medication use in an imperfect world: drug misadventuring as an issue of public policy, part 2. Am J Hosp Pharm1989; 46: 1141–52.
120.
MannMEliassonOPatelKZuWallackRL. A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. Chest1992; 101: 496–9.
121.
MaronideRFChanLSLarsenFJStrandbertLRLaventurierMFSullivanSR. Underutilization of antihypertensive drugs and associated hospitalization. Med Care1989: 27.
122.
MarstonMV. Compliance with medical regimens: a review of the literature. Nurs Res1970; 19: 312–21.
123.
McDowellINewellCRosserW. Comparison of three methods of recalling patients for influenza vaccination. Can Med Assoc J1986; 135: 991–7.
124.
McKenneyJM. Methods of modifying compliance behavior in hypertensive patients. Drug Intell Clin Pharm1981; 15: 8–14.
125.
XXI. Miscellaneous State Pharmacy Laws-(cont.). 1991 NABP survey of pharmacy law. Drug Law56–7.
126.
MorrisLAGrossmanRBarkdollGGordonE. A segmentational analysis of prescription drug information seeking. Med Care1987; 25: 953–64.
127.
MorrisLAHalperinJA. Effects of written drug information on patient knowledge and compliance: a literature review. Am J Public Health1979; 69: 47–52.
128.
MullerRJAgreP. Patient education: a multidisciplinary approach to influence patient compliance. Top Hosp Pharm Manage1991; 10 (4): 50–8.
129.
MurraySJ. Writing prescription instructions. Can Med Assoc J1991; 144 (6): 647–8.
130.
NachtigallLE. Enhancing patient compliance with hormone replacement therapy at menopause. Obstet Gynecol1990; 75 (83S): 77S–80S.
131.
National Pharmaceutical Council. National pharmacy compliance news. 1992;(summer):2–3.
132.
Noncompliance in clinical practice: focus on an interventional program. A special supplement to Drug Topics. Montvale, NJ: Medical Economics Publishing, 1992.
133.
NorellSE. Improving medication compliance: a randomised clinical trial. Br Med J1979; 2: 1031–3.
134.
N Y regulations result in other excesses. Psychiatr News1992; July 3: 4,21.
135.
O'HairDO'HairMJSouthwardGMKrayerKJ. Physician communication and patient compliance. J Compliance Healthcare1987; 2: 125–9.
136.
OlivieriNFMatsuiDHermannCKoren. Compliance assessed by the medication event monitoring system. Arch Dis Child1991; 66: 1399–402.
137.
OlubodunJOFalaseAOColeTO. Drug compliance in hypertensive Nigerians with and without heart failure. Int J Cardiol1990; 27: 229–34.
138.
OmoriDMPotykRPKroenkeK. The adverse effects of hospitalization on drug regimens. Arch Intern Med1991; 151: 1562–4.
139.
OrleansCTSchoenbackVJWagnerEHQuadeDSalmonMAPearsonDSelf-help quit smoking interventions: effects of self-help materials, social support instructions, and telephone counseling. J Consult Clin Psychol1991; 59: 439–48.
140.
OrmerodLPPrescottRJ. Inter-relations between relapses, drug regimens and compliance with treatment in tuberculosis. Respir Med1991; 85: 239–42.
141.
ParkDCMorrellWFrieskeDBlackburnBBirchmoreD. Cognitive factors and the use of over-the-counter medication organizers by arthritis patients. Hum Factors1991; 33: 57–67.
142.
PeckCLKingNJ. Increasing patient compliance with prescriptions. JAMA1982; 248: 2874–7.
143.
PerrinFV. Improving communication with your patients. Drug Topics1988; May 2: 48–54.
144.
PerssonG. Factors related to drug compliance and attrition in neurotic outpatients treated with anxiolytics. Acta Psychiatr Scand1979; 60: 163–9.
145.
Phone messages on prescription drugs offered. Am Pharm1987; NS27 (10): 27.
146.
PlantNRylanceG. Prescribing for children. Practitioner1991; 235: 364–6.
147.
PolitzerB. Lowering the high price of noncompliance. HMO Mag1992; Mar/Apr: 35–7.
148.
PullarT. Compliance with drug therapy. Br J Clin Pharmacol1991; 32: 535–9.
149.
RehderTLMcCoyLKBlackwellBWhiteheadWRobinsonA. Improving medication compliance by counseling and special prescription container. Am J Hosp Pharm1980; 37: 379–85.
150.
ReichmanLB. Compliance in developed nations. Tubercle1987; 68 (2 suppl): 25–9.
151.
ResnickBM. Geriatric motivation: clinically helping the elderly to comply. J Gerontol Nurs1991; 17 (5): 17–20.
RostKRoterD. Predictors of recall of medication regimens and recommendations for lifestyle change in elderly patients. Gerontologist1987; 27: 510–5.
159.
RuffaloRLGarabedian-RuffaloSMPawlsonG. Patient compliance. Am Fam Physician1985; 31 (6): 93–100.
160.
SachsRMBortnichakEA. An evaluation of spontaneous adverse drug reaction monitoring systems. Am J Med1986; 81 (5B): 49–55.
161.
SammonsJH. Written instructions and patient compliance. JAMA1982; 248: 2890.
162.
SaundersLDIrwigLMGearJSSRamushuDL. A randomized controlled trial of compliance improving strategies in Soweto hypertensives. Med Care1991; 29: 669–78.
163.
Schering report looks at pharmacist's role in improving patient compliance. Am J Hosp Pharm1992; 49: 1614, 1616.
164.
SchutteJE. Why fewer patients are out for blood. Med Econ1990; April 23: 56–9.
165.
SclarDA. Improving medication compliance: a review of selected issues. Clin Ther1991; 13: 436–40.
166.
SclarDA. Medication compliance: health policy and pharmacy economics. Aust J Pharm1988; 69: 619–22.
167.
SclarDASkaerTLChinAOkamotoMPGillMA. Utility of a transdermal delivery system for antihypertensive therapy. Part 2. Am J Med1991; 91 (suppl 1A): 57S–60S.
168.
SclarDASkaerTLChinAOkamotoMPNakahiroRKGillMA. Effect of health education in promoting prescription refill compliance among patients with hypertension. Clin Ther1991; 13: 489–95.
169.
SclarDASkaerTLChinAOkamotoMPNakahiroRKGillMA. Effectiveness of the C Cap in promoting prescription refill compliance among patients with glaucoma. Clin Ther1991; 13: 396–400.
170.
Searle starts telephone reminder program for patients taking verapamil product. Am J Hosp Pharm1992; 49: 1613.
171.
SnyderA. Revolt against the professionals. Adweek's Marketing Week1991; Feb 25: 24–5.
172.
SpectorRMcGrathPUretskyNNewmanRCohenP. Does intervention by a nurse improve medication compliance?Arch Intern Med1978; 138: 36–40.
173.
SpectorSL. Is your asthmatic patient really complying?Ann Allergy1985; 55: 552–6.
174.
SteckelSB. Predicting, measuring, implementing and following up on patient compliance. Nurs Clin North Am1982; 17: 491–8.
175.
Talk about prescriptions month fights misuse of prescription drugs. Am Pharm1987; NS27 (10): 27.
176.
TamezEGVacalisTD. Health beliefs, the significant other and compliance with therapeutic regimens among adult Mexican American diabetics. Health Educ1989; Oct/Nov: 24–31.
177.
TaylorJL. Overcoming barriers to blood pressure control in the elderly. Geriatrics1990; 45: 35–8, 43.
178.
To help curb TB, New York workers will watch patients take their medicine. Am J Hosp Pharm1992; 49: 1614.
179.
UkensC. Searle offers wake-up calls for Calan patients. Drug Topics1992; May 4: 15.
180.
ValezaFSMcDougallAC. Blister calendar packs for treatment of tuberculosis. Lancet1990; 335: 473.
181.
WadeJC. Ethical and economic aspects of noncompliance and overtreatment. Can Med Assoc J1990; 142: 204–5.
182.
WandlessIDavieJW. Can drug compliance in the elderly be improved?Br Med J1977; 1: 359–61.
183.
WareGJHolfordNHDavisonJGHarrisRG. Unit dose calendar packaging and elderly patient compliance. N Z Med J1991; 104: 495–7.
184.
WeinsteinAG. Direction, motivation, and successful self-management of asthma: focus on non-compliance. J Asthma1984; 21: 281–3.
185.
WeinsteinAG. Sustained release theophylline for the forgetful asthmatic. Ann Allergy1985; 55: 563–7.
186.
The white paper. Am Pharm1992; NS32 (6): 53.
187.
WilliamsJD. Lower urinary tract infection: rationale and efficacy of single-dose antibacterial therapy. Eur Urol1987; 13: 54–5.
188.
WilliamsRFShepherdMDJowdyAW. Effect of a call-in prescription refill system on workload in an outpatient pharmacy. Am J Hosp Pharm1983; 40: 1954–6.
189.
WindsorRABaileyWCRichardsJMJrManzellaBSoongSJBrooksM. Evaluation of the efficacy and cost effectiveness of health production methods to increase medication adherence among adults with asthma. Am J Public Health1990; 80: 1519–21.
190.
WongBSNormanDC. Evaluation of a novel medication aid, the calendar blister-pak, and its effect on drug compliance in a geriatric outpatient clinic. J Am Geriatr Soc1987; 35: 21–6.